Combining NGS data to gene silencing we provide evidence that the effect of glucose on BC cell sensitivity to tamoxifen is likely mediated by CTGF. Specifically, CTGF silencing induced a significant increase in tamoxifen sensitivity of BC cells grown in HG, at levels similar to those obtained for cells cultured in LG. The gene discussed is CCN2; the disease is breast cancer.